Table of Contents
Good morning from Billionaires.Africa. Here is a brief on what we published yesterday.
Wednesday was a study in wealth being made, questioned and spent — sometimes all at once. The market minted gains at one end; activists and regulators pushed back at the other; and a few builders spent for reasons that had nothing to do with returns.
West & Central Africa — markets, opposition and an exit. Nigeria's Femi Otedola saw his First HoldCo stake climb to about $530 million after the bank's shares surged 9.98% to a record close of N79.35 — a paper windfall, and a marker of how far the Nigerian banking rally has run. Opposition arrived for Africa's biggest project: Greenpeace Africa called for a halt to Aliko Dangote's $17 billion Lamu refinery, warning the 700,000-barrel-a-day plant threatens a fragile coastal ecosystem and wanting all approvals suspended pending an independent impact assessment — the first organised resistance to a project Kenya has embraced as its largest-ever private investment. And PetroNor moved to exit Nigeria, appointing Talanger to sell its Aje oil-field stake and unwinding its partnership with Tunde Folawiyo's Yinka Folawiyo Petroleum.
North Africa — expansion and advantage. In Algeria, Abderrahmane Benhamadi's Condor is pushing deeper into African and European markets, with distribution deals in Rwanda and Tanzania, a new Egyptian subsidiary, and European retailers courting its air conditioners during a severe heatwave — the showcase for Algeria's push to sell something other than oil and gas. In Egypt, a regulatory turn handed an incumbent an edge: a freeze on new fintech lending licences strengthens Mounir Nakhla's MNT-Halan by entrenching those already licensed. And Nassef Sawiris' Aston Villa signed a record shirt sponsorship with Visit Rwanda worth up to £20 million a year — a tourism-marketing play stitched onto a Premier League front.
Southern Africa — scrutiny and purpose. South Africa's Public Investment Corporation suspended its chief executive and drew a regulator's probe over a Lanseria Airport deal linked to Tshepo Mahloele's Harith — a matter now under investigation, with no findings made and the parties entitled to the presumption of innocence. And in Malawi, Thom Mpinganjira — widely described as the country's first billionaire — said he built its only radiotherapy cancer hospital to spare patients costly treatment abroad, not to turn a profit.
Diaspora. Herriot Tabuteau's Axsome Therapeutics won FDA acceptance for a narcolepsy drug, with a regulatory decision due in May 2027 — another step for the biotech built by the Haitian-born billionaire.
The takeaway. A day that showed the full arc of a fortune in motion: made in the market, questioned by activists and regulators, extended into new geographies, and — here and there — spent on something larger than the balance sheet.
On the site
- Nigerian billionaire Femi Otedola's First HoldCo stake hits $530 million at record close
- Aliko Dangote's $17 billion Lamu refinery faces Greenpeace demand for halt over ecosystem risk
- Billionaire Tunde Folawiyo's Aje oil field partner PetroNor moves to exit Nigeria
- Algerian billionaire Abderrahmane Benhamadi's Condor pushes deeper into African and European markets
- Egypt's crackdown on consumer lending strengthens tycoon Mounir Nakhla's MNT-Halan
- Billionaire Nassef Sawiris' Aston Villa signs record Visit Rwanda shirt sponsorship deal
- South Africa's PIC suspends CEO over Lanseria deal linked to billionaire Tshepo Mahloele's Harith
- Malawian billionaire Thom Mpinganjira says he built cancer hospital to save lives, not profit
- Billionaire Herriot Tabuteau's Axsome wins FDA acceptance for narcolepsy drug
Behind the paywall — for paid members
This week's premium briefings are live:
- Elite · Wealth Intelligence — The Refinery Network. How Aliko Dangote's $17 billion Lamu bet turns a single plant into a continental system — timely reading as Greenpeace's challenge lands.
- Executive · Deep-Dive Report — Taking It Private. Nassef Sawiris, OCI Global and the €4.10 endgame.
- Insider · The Inside Story — The Comeback and the Ruin. The paradox of Mohammed Al-Amoudi — worth close to $9 billion, absent from Forbes, a ruined refinery in Morocco and a revival in Addis.
→ Executive ($25/mo): Daily newsletter + Deep-Dive Reports · → Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings. Subscribe
Billionaires.Africa — the world's premier source of news on Africa's billionaires and UHNWIs. Forward to a colleague.
Figures are point-in-time estimates from public sources including Forbes, Bloomberg, company disclosures and exchange filings, as of reporting; they change with markets and currencies and are not measures of liquid wealth. Company valuations, revenues, share stakes and family fortunes are not measures of an individual's personal net worth. Allegations and legal matters are reported as matters of public record; individuals are presumed innocent unless and until proven otherwise, and denials are noted where made. Editorial analysis, not investment, legal or tax advice. © 2026 Billionaires.Africa Inc.
The intelligence satisfies curiosity. The paid briefings satisfy strategy.
Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.
Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.
→ Executive ($25/mo): Daily newsletter + Deep-Dive Reports
→ Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings
Subscribe now
